NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

The Bull Case For Mobileye Global (MBLY) Could Change Following India ADAS Localization Deal With VVDN Technologies

VVDN Technologies announced it has signed a Memorandum of Understanding with Mobileye to localize and deliver advanced driver assistance systems (ADAS) technologies for India’s automotive sector, combining Mobileye’s global expertise with VVDN’s local production and engineering capabilities. This partnership enables Indian automakers greater access to customizable ADAS solutions tailored for domestic and export markets, aligning with rising safety standards and government "Made-in-India"...
NYSE:KNX
NYSE:KNXTransportation

Knight-Swift (KNX): Assessing Valuation After Recent Share Price Rebound

Knight-Swift Transportation Holdings (KNX) shares have seen some movement lately, and investors are watching closely to see how the company’s recent performance lines up with the broader transportation sector. The stock’s year-to-date return remains in focus. See our latest analysis for Knight-Swift Transportation Holdings. After a tough start to the year, Knight-Swift’s 1-day share price return of 4.47% stands out as an encouraging sign. Year-to-date share price return remains down at...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

Is BOK Financial's (BOKF) $400 Million Capital Raise Shifting Its Long-Term Risk and Earnings Profile?

BOK Financial Corporation recently announced a US$0.6300 per share quarterly dividend, payable on November 26, 2025, with an ex-date and record date of November 12, 2025. In addition, BOKF, NA has completed a US$400 million subordinated notes offering to boost its Tier II regulatory capital and fund general corporate purposes. We'll examine how BOK Financial’s US$400 million capital raise could influence its risk profile and longer-term earnings outlook. We've found 16 US stocks that are...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Why Denali Therapeutics (DNLI) Is Down 7.7% After Widening Losses and Key Leadership Changes

Denali Therapeutics recently reported third quarter and nine-month 2025 results, with net losses widening to US$126.9 million and US$383.99 million respectively, while also announcing the departure of its long-standing Chief Medical Officer, Carole Ho, M.D., who will join Eli Lilly, and naming a new board member, Tim Van Hauwermeiren. This combination of financial performance and leadership transition marks a pivotal period for Denali, underscoring both operational challenges and evolving...